Short Term Trading New Year: 27 Dec - 1 Jan, page-108

"MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 28 December 2018: Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) (“Prana” or “the Company” has today announced that it has entered into a securities purchase agreement for a lead investment by Boston based Life Biosciences LLC (“Life Biosciences” to raise up to approximately A$44.5 million (approx. US$31.4 million). Life Biosciences will initially invest US$7.5 million (approx. A$10.6 million), with the agreement allowing Prana to raise an additional US$2 million from other investors, totalling US$9.5 million (approx. A$13.4 million). A further amount of up to approximately A$31 million (approx. US$21.9 million) would be invested by Life Biosciences and other investors on exercise of short-term warrants being issued as part of the transaction"

Seems many may have missed the significance here, PBT is still trading at 3.4 cps with after a US firm with deep pockets and solid credentials just threw $10.6 million at it at a premium and secured the option to throw in another $31m at a larger premium. To get an idea of the quality of Life Biosciences, the CEO Of Logitech Bracken Darrell just took a seat on the board.